What if you'd held CLRB?
A $1,000 investment in Cellectar Biosciences, Inc. (CLRB) at the month-end close of 2005-11 would be worth $0.00000852 at the close of 2026-08 — -100.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $6,169.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2005
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2005 | $1,000 | — |
| 2006 | $435 | -56.5% |
| 2007 | $295 | -32.2% |
| 2008 | $235 | -20.3% |
| 2009 | $1,260 | +436.2% |
| 2010 | $15.00 | -98.8% |
| 2011 | $1.44 | -90.4% |
| 2012 | $2.42 | +68.2% |
| 2013 | $1.21 | -50.0% |
| 2014 | $0.50 | -58.2% |
| 2015 | $0.12 | -76.1% |
| 2016 | $0.02 | -83.5% |
| 2017 | $0.02 | +12.3% |
| 2018 | $0.002533 | -88.7% |
| 2019 | $0.003676 | +45.2% |
| 2020 | $0.003399 | -7.6% |
| 2021 | $0.001078 | -68.3% |
| 2022 | $0.0002794 | -74.1% |
| 2023 | $0.0004526 | +62.0% |
| 2024 | $0.00004902 | -89.2% |
| 2025 | $0.00001607 | -67.2% |
| 2026 | $0.00001427 | -11.2% |
Best and worst month-end to buy
The best single month-end close to have bought CLRB was 2026-07 ($2.53): $1,000 then is $1,036 today. The worst was 2005-11 ($307.53M): $1,000 then is $0.00000852.
FAQ
What would $1,000 in CLRB be worth today?
A $1,000 investment in Cellectar Biosciences, Inc. (CLRB) at the start of 2005 would be worth about $0.00000852 today, a total return of -100.0%. Dividends are reinvested in these figures.
What were the best and worst years for CLRB?
Cellectar Biosciences, Inc. (CLRB)'s strongest calendar year since 2005 was 2009, a +436.2% return — $1,000 held through that year became about $5,362 by year-end. Its weakest year was 2010, at -98.8%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in CLRB have grown?
Investing $100 at the end of every month since 2005-11 would have grown to about $1,518 on $25,000 invested.
Did CLRB beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $6,169. CLRB trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Cellectar Biosciences, Inc. (CLRB) historical total-return data from 2005-11 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.